NewVac LLC
Clinical Trials
2
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)โข Click on a phase to view related trials
Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy
- Conditions
- Ovarian Cancer
- Interventions
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- NewVac LLC
- Target Recruit Count
- 31
- Registration Number
- NCT02948075
- Locations
- ๐ท๐บ
Federal State budget Scientific Agency "Russian Oncological Research Center n.a. N.N. Blokhin", Moscow, Russian Federation
๐ท๐บMedical Radiological Scientific Center n.a. A.F. Tsyb - branch of Federal State Budget Agency "Public Medical Scientific Radiology Center" of Ministry of Health of Russian Federation, Obninsk, Russian Federation
๐ท๐บState Budget Agency of Stavropol Territory Healthcare Pyatigorsk Oncologic Dispensary, Pyatigorsk, Russian Federation
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy
- Conditions
- Non-small Cell Lung CancerEpithelial Ovarian Cancer
- Interventions
- First Posted Date
- 2016-04-05
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- NewVac LLC
- Target Recruit Count
- 51
- Registration Number
- NCT02728492
- Locations
- ๐ท๐บ
Russian Oncological Research Center n.a. N. N. Blokhin RAMS, Moscow, Russian Federation
๐ท๐บState Budgetary Healthcare Institution of Stavropol Territory "Pyatigorsk oncology dispensary", Pyatigorsk, Russian Federation
๐ท๐บSaint-Peterburg State Budgetary healthcare Institution "City Clinical Oncology Dispensary", Saint-Petersburg, Russian Federation